|
|
Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
Daphné Morel
,
Daniel Jeffery
,
Sandrine Aspeslagh
,
Geneviève Almouzni
,
Sophie Postel-Vinay
et al.
Journal articles
hal-02371032v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks
Hélène Neyret-Kahn
,
Jacqueline Fontugne
,
Xiang Yu Meng
,
Clarice Groeneveld
,
Luc Cabel
et al.
2022
Preprints, Working Papers, ...
hal-03854062v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CENP-A overexpression promotes distinct fates in human cells, depending on p53 status
Daniel Jeffery
,
Alberto Gatto
,
Katrina Podsypanina
,
Charlène Renaud-Pageot
,
Rebeca Ponce Landete
et al.
Journal articles
hal-03184130v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CENP-A overexpression promotes distinct fates in human cells, depending on p53 status
Daniel Jeffery
,
Alberto Gatto
,
Katrina Podsypanina
,
Charlène Renaud-Pageot
,
Rebeca Ponce Landete
et al.
Journal articles
hal-03452720v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chromatin Dynamics in Cancer: Epigenetic Parameters and Cellular Fate—Histone Variants and Their Chaperones: New Targets?
Daniel Jeffery
,
Katrina Podsypanina
,
Tejas Yadav
,
Geneviève Almouzni
Book sections
hal-02371158v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|